Cardiac arrest & resuscitation

Blood biomarkers for the prediction of outcome after cardiac arrest: an international prospective observational study within the Targeted Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial

Lancet Respir MedPublished Prospective observational biomarker study within the TTM2 randomised trial

Authors' conclusion

Neurofilament light is a highly accurate predictor of long-term outcome after cardiac arrest and superior to other relevant biomarkers evaluated in this study.

Study context

Population
Adults with OHCA of presumed cardiac or unknown cause, unconscious after arrest; serum sampled at 0, 24, 48 and 72 h after ICU admissionof 932 eligible
Participants
819 adults
Comparison
Neurofilament light vs glial fibrillary acidic protein, neuron-specific enolase and S100 for outcome prediction
Primary endpoint
Good (modified Rankin Scale 0-3) or poor (modified Rankin Scale 4-6) functional outcome; prognostic accuracy by AUROC
Follow-up
6 months
Methodological detailsinternational, 24 European hospitals, pre-specified Bonferroni correction (p<0.0125)
  • International
  • 24 European hospitals
  • Pre-specified Bonferroni correction (p<0.0125)

Primary result

As reported in the abstract

Prediction of functional outcome (AUROC at 0, 24, 48, 72 h)
GroupAUROC 0 hAUROC 24 hAUROC 48 hAUROC 72 h
Neurofilament light0.77 (95% CI 0.73-0.80)0.92 (0.90-0.94)0.93 (0.91-0.95)0.93 (0.91-0.95)
Glial fibrillary acidic protein0.74 (95% CI 0.70-0.77)0.87 (0.84-0.90)0.87 (0.84-0.90)0.87 (0.84-0.91)
Neuron-specific enolase0.61 (95% CI 0.56-0.65)0.78 (0.75-0.82)0.85 (0.81-0.88)0.86 (0.82-0.89)
S1000.74 (95% CI 0.71-0.78)0.84 (0.81-0.87)0.79 (0.75-0.82)0.78 (0.74-0.82)

AUROC 0 h

Neurofilament light0.77 (95% CI 0.73-0.80)
Glial fibrillary acidic protein0.74 (95% CI 0.70-0.77)
Neuron-specific enolase0.61 (95% CI 0.56-0.65)
S1000.74 (95% CI 0.71-0.78)

AUROC 24 h

Neurofilament light0.92 (0.90-0.94)
Glial fibrillary acidic protein0.87 (0.84-0.90)
Neuron-specific enolase0.78 (0.75-0.82)
S1000.84 (0.81-0.87)

AUROC 48 h

Neurofilament light0.93 (0.91-0.95)
Glial fibrillary acidic protein0.87 (0.84-0.90)
Neuron-specific enolase0.85 (0.81-0.88)
S1000.79 (0.75-0.82)

AUROC 72 h

Neurofilament light0.93 (0.91-0.95)
Glial fibrillary acidic protein0.87 (0.84-0.91)
Neuron-specific enolase0.86 (0.82-0.89)
S1000.78 (0.74-0.82)
  • Neurofilament light vs Glial fibrillary acidic protein: P < 0.0001 — significantly higher at 24, 48 and 72 h
  • Neurofilament light vs Glial fibrillary acidic protein: P = 0.27 — not significant at 0 h

Original publication

Blood biomarkers for the prediction of outcome after cardiac arrest: an international prospective observational study within the Targeted Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial. Lancet Respir Med. Published 11 December 2025. doi:10.1016/s2213-2600(25)00363-7

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.